Flatiron Health and the Information Exchange and Data Transformation (INFORMED) Program at the U.S. Food and Drug Admini...
Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals announced that Novartis has exercised its option to licen...
Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drug...
GE has announced a definitive agreement to sell its BioPharma business to Danaher Corporation for a total consideration ...
Data recently published in Clinical Cancer Research demonstrate the advantages of using an ultra-high sensitiv...
Pfizer recently announced that the European Commission (EC) has approved ZIRABEV for the treatment of metastatic ca...
Roche and Spark Therapeutics have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeuti...
AbbVie, biopharmaceutical company and Voyager Therapeutics, a clinical-stage gene therapy company focused on developing ...
Merck announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supp...
Insilico Biotechnology AG and Teva Pharmaceutical Industries Ltd. have announced an agreement to apply Insilico’s ...
Spending on health is growing faster than the rest of the global economy, accounting for 10% of global gross domestic pr...
Merck , known as MSD outside the United States and Canada, and Immune Design, has announced that the companies have ente...
Mallinckrodt plc, a leading global specialty pharmaceutical company has announced interim analysis results of its compan...
The Global Commission to End the Diagnostic Odyssey for Children , co-chaired by Takeda, Microsoft and EURORDIS-Rare Dis...
Aveanna Healthcare, a leading home healthcare company has announced that it has entered into a definitive agreement to a...
AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and Calypso Biotech B.V...
Novartis has announced that the US Food and Drug Administration (FDA) approval of Egaten (triclabendazole) for the treat...
Merck, a leading science and technology company and leader in genome editing, announced that the United States Pate...
